Aethir vs Bio Protocol — how do they compare? Aethir trades at Rp69.76 (market cap Rp1,41T, Rp93,39M 24h volume), while Bio Protocol trades at Rp439.84 (market cap Rp1T, Rp164,77M 24h volume). The key difference: Aethir is the larger of the two by market cap, and Aethir's circulating supply is 20,1B / 42B ATH (48%) versus 2,3B / 3,3B BIO (69%) for Bio Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Aethir for 39 Days and Bio Protocol for 18 Days on average.
| ATH | BIO | |
|---|---|---|
Market Cap | Rp1,41T | Rp1T |
Volume (24h) | Rp93,39M | Rp164,77M |
Circulating Supply | 20,1B / 42B ATH (48%) | 2,3B / 3,3B BIO (69%) |
Typical Hold Time | 39 Days | 18 Days |
What Pluang investors did over the last 30 days
Aethir is best described as distributed cloud compute infrastructure. It aggregates enterprise-grade GPU chips into a single global network to increase the supply of on-demand cloud compute resources for the AI, gaming, and virtualized compute sectors.
Read more on ATH →BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →